Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Binimetinib, MEK1/2, Encorafenib, BRAF and the tag subtype-page.
Shares Dabrafenib, Trametinib, BRAF, Pembrolizumab and the tag subtype-page.
Shares Dabrafenib, Trametinib, BRAF and the tag subtype-page.
Shares BRAF, Atezolizumab, Nivolumab, Pembrolizumab and the tag subtype-page.
Shares Encorafenib, BRAF, Pembrolizumab and the tag subtype-page.
Shares MEK1/2, RAS / RAF / MEK / ERK (MAPK) and the tag subtype-page.
Shares Brain metastases (secondary brain tumours), Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS) and the tag subtype-page.
Shares Nivolumab, Pembrolizumab, Immune checkpoint inhibitors and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.